Kimball Electronics projects fiscal 2027 net sales of $1.535 billion to $1.56 billion, including $60 million from its Helvoet acquisition. The company expects organic sales growth of 3% to 5%, with Medical organic growth in the high single to low double-digit range, Industrial in line with the company average, and Automotive flattish for the year. Adjusted operating income is estimated at 4.4% to 4.7% of net sales, and capital expenditures are expected to be $50 million to $60 million. Management said the dilutive impact of the Indianapolis facility ramp is roughly offset by the accretive benefit from Helvoet. For the fourth quarter, net sales were $371.6 million, adjusted operating income was $18.1 million or 4.9% of net sales, and cash from operations was $42.4 million.
Kimball ElectronicsCompany provides fiscal 2027 guidance with expected sales growth and adjusted operating income margin, indicating positive outlook.
Helvoet acquisition is mentioned as contributing $60 million to sales and accretive benefit, indicating positive impact.
